Thymagen for Thymus Health & Immune System Support — Bioregulators
Khavinson bioregulator peptide for thymic tissue regeneration and immune function optimization.
Overview
Thymagen is a Khavinson bioregulator targeting the thymus gland for immune system optimization and T-cell function support. Through DNA-level gene regulation in thymic tissues, Thymagen promotes thymus regeneration, enhances immune cell production, and supports immunological health. It's particularly valuable for age-related thymic involution, immune senescence, chronic illness recovery, and immune system maintenance. Thymagen is closely related to pharmaceutical-grade Thymalin.
Indications
- Age-related immune decline (immunosenescence)
- Thymic tissue regeneration
- T-cell function optimization
- Chronic illness immune recovery
- Post-infection immune restoration
- Autoimmune condition support (emerging)
- Athletic immune system maintenance
Mechanism of Action
Age-related thymus shrinkage, reduced T-cell production, or immune senescence
Dosing
| Compound | Dose | Frequency | Notes |
|---|---|---|---|
| Thymagen | 20 mg | Once daily | Immune health maintenance and thymic support |
| Thymagen | 20 mg | Twice daily for first 2 months, then once daily | For immune deficiency or post-illness recovery |
Evidence Grade
GRADE C
Safety & Contraindications
- Well-studied bioregulator with favorable immune safety profile
- No immune toxicity reported in clinical studies
- Monitor immune markers in autoimmune conditions
- Not a replacement for immunosuppressive or immunomodulatory medications
- Consult immunologist with autoimmune disease or immune deficiency
- Safe for long-term immune support based on clinical data